Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Abuaku, Benjamin ^a   Duah, Nancy ^a   Quaye, Lydia ^a   Quashie, Neils ^a,b   Koram, Kwadwo ^a  

^a University of Ghana   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

Author keywords

Artemether lumefantrine; Ecological zones; Ghana; Therapeutic efficacy; Uncomplicated malaria

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ALLELE; ARTICLE; CHILD; DRUG EFFICACY; FEMALE; FEVER; GAMETOCYTE; GHANA; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; PARASITE CLEARANCE; PARASITEMIA; POLYMERASE CHAIN REACTION; DRUG COMBINATION; PRESCHOOL CHILD; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; GHANA; HUMANS; INFANT; MALARIA; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84869881240     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-388     Document Type: Article

References (29)

1. WHO, World Malaria Report 2011 Geneva: World Health Organization 2011
2. Ministry of Health, National Malaria Control Programme 2010 Annual Report
3. Koram KA, Mapping response of Plasmodium falciparum to chloroquine and other antimalarial drugs in Ghana, Project ID 980034 Accra: NMIMR 2003 Final report submitted to MIM/TDR
4. WHO, Monitoring Antimalarial Drug Resistance: Report of a WHO Consultation. 3-5 December 2001 Geneva: World Health Organization 2002
5. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5years in Ghana. Koram KA, Abuaku B, Duah N, Quashie N, Acta Trop 2005 95 194 203 10.1016/j. actatropica.2005.06.018 16054584
6. Ghana Health Service, Final Draft. Antimalarial Drug Policy for Ghana Accra: GHS 2004
7. Ministry of Health, Guidelines for case management of malaria in Ghana Accra: MOH 2009
8. WHO, Methods for surveillance of antimalarial drug efficacy Geneva: World Health Organization 2009
9. Ghana Statistical Service, 2010 population & housing census. Summary report of final results GSS 2012 23213178
10. Ghana, Duration of the Malaria Transmission Season http://www.mara.org. za/pdfmaps/GhaSeasonality.PDF
11. Severe falciparum malaria in young children of the Kassena-Nankana district of northern Ghana. Oduro AR, Koram KA, Rogers W, Atuguba F, Ansah P, Anyorigiya T, Ansah A, Anto F, Mensah N, Hodgson A, Nkrumah F, Malar J 2007 6 96 10.1186/1475-2875-6-96 17662142
12. Malaria transmission in two rural communities in the forest zone of Ghana. Abonuusum A, Owusu-Daako K, Tannich E, May J, Garms R, Kruppa T, Parasitol Res 2011 108 1465 1471 10.1007/s00436-010-2195-1 21153839
13. Genetic diversity of polymorphic vaccine candidate antigens (apical membrane antigen-1, merozoite surface protein-3, and erythrocyte binding antigen-175) in Plasmodium falciparum isolates from Western and Central Africa. Soulama I, Bigoga JD, Ndiaye M, Bougouma EC, Quagraine J, Casimiro PN, Stedman TT, Sirima SB, Am J Trop Med Hyg 2011 84 276 284 10.4269/ajtmh.2011.10-0365 21292899
14. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Adjei GO, Kurtzhals JA, Rodrigues OP, Alifrangis M, Hoegberg LC, Kitcher ED, Badoe EV, Lamptey R, Goka BQ, Malar J 2008 7 127 10.1186/1475-2875-7-127 18620577
15. High efficacy of two artemisinin-based combinations (artemether- lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria. Falade CO, Ogundele AO, Yusuf BO, Ademowo OG, Ladipo SM, Trop Med Int Health 2008 13 635 643 10.1111/j.1365-3156.2008.02043.x 18346028
16. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. Faye B, Ndiaye JL, Ndiaye D, Dieng Y, Faye O, Gaye O, Malar J 2007 6 80 10.1186/1475-2875-6-80 17570848
17. A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali. Sagara I, Dicko A, Djimde A, Guindo O, Kone M, Tolo Y, Thera MA, Sogoba M, Fofana M, Ouattara A, Sissoko M, Jansen HF, Doumbo OK, Am J Trop Med Hyg 2006 75 630 636 17038684
18. Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum Malaria in Southwestern Nigeria. Sowunmi A, Gbotosho GO, Happi CT, Adedeji AA, Fehintola FA, Folarin OA, Tambo E, Fateye BA, Am J Trop Med Hyg 2007 77 235 241 17690392
19. A randomized trial to assess the safety and efficacy of artemether-lumfantrine (Coartem®) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda. Fanello CI, Karema C, Doren WV, Overmeir CV, Ngamije D, D'Alessandro U, Trans R Soc Trop Med Hyg 2007 101 344 350 10.1016/j.trstmh.2006.06.010 17005222
20. High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola. Guthmann JP, Cohuet S, Rigutto C, Fortes F, Saraiva N, Kiguli J, Kyomuhendo J, Francis M, Noel F, Mulemba M, Balkan S, Am J Trop Med Hyg 2006 75 1 143 145 16837721
21. Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveler with Plasmodium falciparum malaria after returning from Tanzania. Färnert A, Ursing J, Tolfvenstam T, Rono J, Karlsson L, Sparrelid E, Lindegårdh N, Malar J 2012 11 176 10.1186/1475-2875-11-176 22632033
22. Early variations in Plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance. Michael OS, Gbotosho GO, Folarin OA, Okuboyejo T, Sowunmi A, Oduola AM, Happi CT, Malar J 2010 9 335 10.1186/1475-2875-9-335 21092220
23. Artemisinin derivatives for treating severe malaria. McIntosh HM, Olliaro P, Cochrane Database Syst Rev 2000 2 D000527 10796551
24. Factors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children. Sowunmi A, Adewoye EO, Gbotsho GO, Happi CT, Sijuade A, Folarin OA, Okuboyejo TM, Michael OS, Malar J 2010 9 53 10.1186/1475-2875-9-53 20156350
25. WHO, Antimalarial drug combination therapy. Report of a WHO Technical consultation, 4-5 April 2001 Geneva: World Health Organization 2001
26. Safety and efficacy of lumefantrine-artemether (Coartem®) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults. Mulenga M, JP Vg, Mwananyanda L, Chalwe V, Moerman F, Chilengi R, Overmeir CV, Dujardin JC, D'Alessandro U, Malar J 2006 5 73 10.1186/1475-2875-5-73 16923176
27. An open label, randomized trial of artesunate + amodiaquine, artesunate + chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria. Owusu-Agyei S, Asante KP, Owusu R, Adjuik M, Amenga-Etego S, Dosoo DK, Gyapong J, Greenwood B, Chandramohan D, PLoS ONE 2008 3 2530 10.1371/journal.pone.0002530 18575626
28. Benefits of using multiple first-line therapies against malaria. Boni MF, Smith DL, Laxminarayan R, Proc Natl Acad Sci USA 2008 105 14216 14221 10.1073/pnas.0804628105 18780786
29. Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty. Smith DL, Klein EY, Mckenzie FE, Laxminarayan R, Malar J 2010 9 217 10.1186/1475-2875-9-217 20653960